Boston Scientific to buy Schneider

Article

Catheter developer Boston Scientific of Natick, MA, announced this month the signing of an agreement to purchase Schneider Worldwide, a division of Pfizer's Medical Technology Group, for $2.1 billion in cash, pending regulatory approvals. Schneider

Catheter developer Boston Scientific of Natick, MA, announced this month the signing of an agreement to purchase Schneider Worldwide, a division of Pfizer's Medical Technology Group, for $2.1 billion in cash, pending regulatory approvals. Schneider Worldwide operates out of Bulach, Switzerland, and manufactures stents and angioplasty devices and accessories. Last year the division claimed sales of $330 million. The deal should close later this year.

By acquiring Schneider, Boston Scientific will gain access to high-growth areas of interventional medicine, and will be able to offer a broader range of products, including rapid exchange catheters and nylon balloon technology. The deal reflects Boston Scientific's strategy of expanding its share in the interventional medicine market: Last year the company acquired Target Therapeutics of Fremont, CA, another catheter developer with a solid position in interventional neuroradiology.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.